Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AVACTA GROUP PLC Director's Dealing 2014

May 9, 2014

7507_dirs_2014-05-09_c341cb99-101c-4411-a3ae-5d8db9a2d030.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7675G

Avacta Group PLC

09 May 2014

Avacta Group plc

("Avacta" or the "Group")

Director's dealing

Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, announces that Craig Slater, Chief Operating Officer of the Group, has today purchased 641,025 Ordinary Shares of 0.1p each in the Group at a price of 1.17 pence per share.

Following this transaction, Mr Slater's total interest in the Group is 34,723,111 Ordinary Shares of 0.1p each, representing approximately 0.9% of Avacta's issued share capital.

Enquiries:

Avacta Group plc Tel:  +44 (0) 844 414 0452
Alastair Smith, Chief Executive Officer www.avacta.com
Tim Sykes, Chief Financial Officer
Numis Securities Limited Tel:  +44 (0) 207 260 1000
Michael Meade / Freddie Barnfield - Nominated Adviser www.numiscorp.com
James Black - Corporate Broking
Walbrook PR Ltd Tel: +44 (0) 20 7933 8780 or [email protected]
Anna Dunphy Mob: +44 (0)7876 741 001
Lianne Cawthorne Mob: +44 (0)7584 391 303

About Avacta Group plc - www.avacta.com

Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:

Avacta Analytical

www.avactaanalytical.com
High throughput analysis instrument, Optim, to help reduce the cost and risk of drug development.
Avacta Animal Health

www.avactaanimalhealth.com
Veterinary diagnostics reference laboratory, diagnostic kits and newly launched in-clinic blood analyser, Sensipod.
Avacta Life Sciences

www.avactalifesciences.com
Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development.

Avacta joined AIM in August 2006 and is based in Wetherby, England.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSLLFLEEEIAIIS